Novartis picks Precision Bio to bring in vivo gene editing meds to blood disorders
9 days ago - By MedCity News
Novartis is paying Precision Bio $75 million up front to begin a partnership aiming to develop in vivo gene-editing therapies for serious genetic blood disorders, such as sickle cell disease. One of the goals of the alliance is to make genetic medicines more globally accessible.
Read more ...
The headlines of Care Mag
Vladimir Zelenko, 48, Dies; Promoted an Unfounded Covid Treatment
A self-described “simple country doctor,” he won national attention in 2020 when the White House embraced his hydroxychloroquine regimen.
PSA: Vitamin C Supplements Can Cause These Surprising Side Effects
Some things to look out for when taking vitamin C.
Keep This On Your Nightstand For Super-Steamy, More Confident Sex
Here's how to use it-tonight?
Novartis pays $100M to get Mallinckrodt's ticket for a speedier FDA drug review
Novartis is acquiring an FDA priority review voucher from Mallinckrodt Pharmaceuticals. The $100 million price tag is in the neighborhood of the going rate for these vouchers...
Amazon Is Selling A Ton Of These Chic Tops & Dresses That Don't Cling To...
The longer I've been working from home, the more I've learned to embrace comfy outfits that are also chic - think: soft, flowing fabrics that don't fit too tightly. Whether...
Please Stop Making This Common Mistake When Choosing A Healthy Olive Oil
Not all EVOO is created equal.
Material: A New Range Of Kitchenware Mamas Love
If you've heard about Material it's probably because the brand has gone viral on Instagram thanks to influencers like Eva Chen and Megan Roup. Kitchenware isn't usually all...
These Anti-Snore Pillows Might Just Save Your Relationship
Prepare for the best sleep ever.
The SPF Julianne Hough Calls a ‘Best Friend' Is on Super Sale at SkinStore...
It's a go-to for a ton of celebs.
This Award-Winning Hyaluronic Acid Serum Is a Game Changer for Dry Skin
It restores that youthful, healthy-looking bounce and glow.